Login / Signup

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis.

Bernardete PessoaLuísa MalheiroInês CarneiroSílvia MonteiroJoão CoelhoConstanca CoelhoJoão FigueiraAngelina MeirelesJoão Nuno Melo Beirão
Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)
In persistent DME unresponsive to bevacizumab, both anatomical and functional improvements were observed with ranibizumab whereas aflibercept only showed an anatomical improvement. Clinicaltrials.gov NCT04018833.
Keyphrases
  • age related macular degeneration
  • metastatic colorectal cancer
  • diabetic retinopathy
  • optical coherence tomography
  • vascular endothelial growth factor